U Jonas
Overview
Explore the profile of U Jonas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
314
Citations
2396
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Merseburger A, VON DER Heyde E, Kobierski A, Wegener U, Mengel M, Jonas U, et al.
Cancer Genomics Proteomics
. 2019 Aug;
3(3-4):239-244.
PMID: 31394703
Background: The expression of the negative cell cycle regulator p27 is frequently found to be deregulated in various human cancer types. Whether the expression of p27 can be used as...
2.
Choritz L, Wegner M, Forch R, Jonas U, Thieme H
Ophthalmologe
. 2013 Jul;
110(8):714-21.
PMID: 23821233
Episcleral glaucoma drainage implants (GDI) are being used increasingly more as a surgical option for lowering intraocular pressure (IOP). One of the main reasons for failure to control IOP is...
3.
Grunewald V, Hofner K, Thon W, Kuczyk M, Jonas U
Restor Neurol Neurosci
. 2012 Mar;
14(2):189-93.
PMID: 22387515
Temporary electrical stimulation using anal or vaginal electrodes and an external pulse generator has been a treatment modality for urinary urge incontinence for nearly three decades. In 1981 Tanagho and...
4.
Kuczyk M, Serth J, Bokemeyer C, Hofner K, Allhoff E, Jonas U
Oncol Rep
. 2011 May;
1(6):1247-51.
PMID: 21607525
Lysosomal proteases may be involved in facilitating cancer invasion and metastatic spread by degradation of basement membranes and intercellular matrix. Overexpression of cathepsin D, a lysosomal aspartyl protease, has been...
5.
Bokemeyer C, Kuczyk M, Fichna B, Jonas U, Poliwoda H, Schmoll H
Oncol Rep
. 2011 May;
2(4):615-8.
PMID: 21597787
This report describes the unusual case of a patient with late relapse of testicular cancer, histologically defined as differentiated teratoma occurring 76 months after primary therapy for metastatic non-seminomatous germ...
6.
Enzyme-assisted synthesis and structural characterization of pure benzodiazepine glucuronide epimers
Pallmann T, Jonas U, Wagner M, Thevis M, Kaeferstein H, Rothschild M, et al.
Eur J Pharm Sci
. 2009 Dec;
39(4):233-40.
PMID: 20036738
The three hydroxybenzodiazepines oxazepam, temazepam, and lorazepam used for their anxiolytic, sedative, and anticonvulsant properties are metabolized by glucuronidation, which is the predominant pathway in the clearance mechanism of exogenous...
7.
Hofner K, Burkart M, Jacob G, Jonas U
World J Urol
. 2009 Dec;
28(3):353-7.
PMID: 19997921
Objectives: To investigate the symptomatic and quality of life (QoL) response to treatment with tolterodine extended release (ER) in subgroups of male patients with Overactive Bladder Syndrome (OAB) and LUTS...
8.
Still T, Sainidou R, Retsch M, Jonas U, Spahn P, Hellmann G, et al.
Nano Lett
. 2008 Sep;
8(10):3194-9.
PMID: 18767884
We report on the first measurement of elastic vibrational modes in core-shell spheres (silica-poly(methyl methacrylate), SiO2-PMMA) and corresponding spherical hollow capsules (PMMA) with different particle size and shell thickness using...
9.
Still T, Cheng W, Retsch M, Sainidou R, Wang J, Jonas U, et al.
Phys Rev Lett
. 2008 Jun;
100(19):194301.
PMID: 18518452
We report on the observation of two hypersonic phononic gaps of different nature in three-dimensional colloidal films of nanospheres using Brillouin light scattering. One is a Bragg gap occurring at...
10.
Hofner K, Burkart M, Jacob G, Jonas U
World J Urol
. 2007 Oct;
25(6):627-33.
PMID: 17906864
Patients with presumed non-obstructive BPH (Q (max )>or= 15 ml/s) treated with tolterodine ER 4 mg/day for OAB symptoms, alone or added to unsuccessful alpha-blocker treatment of >or=6 weeks duration,...